nodes	percent_of_prediction	percent_of_DWPC	metapath
Palonosetron—CYP1A2—Dacarbazine—sarcoma	0.168	0.261	CbGbCtD
Palonosetron—CYP3A4—Thiotepa—sarcoma	0.159	0.247	CbGbCtD
Palonosetron—CYP1A2—Etoposide—sarcoma	0.0823	0.128	CbGbCtD
Palonosetron—CYP3A4—Mitoxantrone—sarcoma	0.0684	0.106	CbGbCtD
Palonosetron—CYP3A4—Vincristine—sarcoma	0.047	0.0731	CbGbCtD
Palonosetron—CYP2D6—Doxorubicin—sarcoma	0.0462	0.0719	CbGbCtD
Palonosetron—CYP3A4—Etoposide—sarcoma	0.0431	0.067	CbGbCtD
Palonosetron—CYP3A4—Doxorubicin—sarcoma	0.0294	0.0457	CbGbCtD
Palonosetron—Fatigue—Thiotepa—sarcoma	0.00085	0.00238	CcSEcCtD
Palonosetron—Dysgeusia—Etoposide—sarcoma	0.00085	0.00238	CcSEcCtD
Palonosetron—Infection—Mitoxantrone—sarcoma	0.000846	0.00237	CcSEcCtD
Palonosetron—Fatigue—Dactinomycin—sarcoma	0.000844	0.00237	CcSEcCtD
Palonosetron—Constipation—Thiotepa—sarcoma	0.000843	0.00236	CcSEcCtD
Palonosetron—Pain—Thiotepa—sarcoma	0.000843	0.00236	CcSEcCtD
Palonosetron—Shock—Mitoxantrone—sarcoma	0.000838	0.00235	CcSEcCtD
Palonosetron—Pain—Dactinomycin—sarcoma	0.000837	0.00235	CcSEcCtD
Palonosetron—Anaphylactoid reaction—Epirubicin—sarcoma	0.000834	0.00234	CcSEcCtD
Palonosetron—Anorexia—Vincristine—sarcoma	0.000833	0.00234	CcSEcCtD
Palonosetron—Tachycardia—Mitoxantrone—sarcoma	0.000831	0.00233	CcSEcCtD
Palonosetron—Skin disorder—Mitoxantrone—sarcoma	0.000827	0.00232	CcSEcCtD
Palonosetron—Hypotension—Vincristine—sarcoma	0.000817	0.00229	CcSEcCtD
Palonosetron—Anorexia—Mitoxantrone—sarcoma	0.000811	0.00228	CcSEcCtD
Palonosetron—Pain in extremity—Epirubicin—sarcoma	0.000808	0.00227	CcSEcCtD
Palonosetron—Gastrointestinal pain—Thiotepa—sarcoma	0.000806	0.00226	CcSEcCtD
Palonosetron—Anaemia—Etoposide—sarcoma	0.000802	0.00225	CcSEcCtD
Palonosetron—Gastrointestinal pain—Dactinomycin—sarcoma	0.0008	0.00224	CcSEcCtD
Palonosetron—Hot flush—Doxorubicin—sarcoma	0.000799	0.00224	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Vincristine—sarcoma	0.000796	0.00223	CcSEcCtD
Palonosetron—Hypotension—Mitoxantrone—sarcoma	0.000795	0.00223	CcSEcCtD
Palonosetron—Menopausal symptoms—Doxorubicin—sarcoma	0.000792	0.00222	CcSEcCtD
Palonosetron—Insomnia—Vincristine—sarcoma	0.000791	0.00222	CcSEcCtD
Palonosetron—Paraesthesia—Vincristine—sarcoma	0.000785	0.0022	CcSEcCtD
Palonosetron—Abdominal pain—Thiotepa—sarcoma	0.000779	0.00219	CcSEcCtD
Palonosetron—Body temperature increased—Thiotepa—sarcoma	0.000779	0.00219	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000776	0.00218	CcSEcCtD
Palonosetron—Body temperature increased—Dactinomycin—sarcoma	0.000773	0.00217	CcSEcCtD
Palonosetron—Abdominal pain—Dactinomycin—sarcoma	0.000773	0.00217	CcSEcCtD
Palonosetron—Anaphylactoid reaction—Doxorubicin—sarcoma	0.000772	0.00217	CcSEcCtD
Palonosetron—Paraesthesia—Mitoxantrone—sarcoma	0.000764	0.00214	CcSEcCtD
Palonosetron—Decreased appetite—Vincristine—sarcoma	0.00076	0.00213	CcSEcCtD
Palonosetron—Dyspnoea—Mitoxantrone—sarcoma	0.000759	0.00213	CcSEcCtD
Palonosetron—Somnolence—Mitoxantrone—sarcoma	0.000757	0.00212	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Vincristine—sarcoma	0.000755	0.00212	CcSEcCtD
Palonosetron—Fatigue—Vincristine—sarcoma	0.000754	0.00211	CcSEcCtD
Palonosetron—Convulsion—Etoposide—sarcoma	0.000752	0.00211	CcSEcCtD
Palonosetron—Dyspepsia—Mitoxantrone—sarcoma	0.000749	0.0021	CcSEcCtD
Palonosetron—Hypertension—Etoposide—sarcoma	0.000749	0.0021	CcSEcCtD
Palonosetron—Pain—Vincristine—sarcoma	0.000748	0.0021	CcSEcCtD
Palonosetron—Constipation—Vincristine—sarcoma	0.000748	0.0021	CcSEcCtD
Palonosetron—Pain in extremity—Doxorubicin—sarcoma	0.000747	0.0021	CcSEcCtD
Palonosetron—Decreased appetite—Mitoxantrone—sarcoma	0.00074	0.00208	CcSEcCtD
Palonosetron—Abdominal pain upper—Epirubicin—sarcoma	0.000738	0.00207	CcSEcCtD
Palonosetron—Hypokalaemia—Epirubicin—sarcoma	0.000735	0.00206	CcSEcCtD
Palonosetron—Fatigue—Mitoxantrone—sarcoma	0.000734	0.00206	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000734	0.00206	CcSEcCtD
Palonosetron—Discomfort—Etoposide—sarcoma	0.00073	0.00205	CcSEcCtD
Palonosetron—Pain—Mitoxantrone—sarcoma	0.000728	0.00204	CcSEcCtD
Palonosetron—Constipation—Mitoxantrone—sarcoma	0.000728	0.00204	CcSEcCtD
Palonosetron—Aspartate aminotransferase increased—Epirubicin—sarcoma	0.000727	0.00204	CcSEcCtD
Palonosetron—Hypersensitivity—Thiotepa—sarcoma	0.000726	0.00204	CcSEcCtD
Palonosetron—Hypersensitivity—Dactinomycin—sarcoma	0.000721	0.00202	CcSEcCtD
Palonosetron—Gastrointestinal pain—Vincristine—sarcoma	0.000715	0.00201	CcSEcCtD
Palonosetron—Gastritis—Epirubicin—sarcoma	0.000715	0.00201	CcSEcCtD
Palonosetron—Anaphylactic shock—Etoposide—sarcoma	0.000708	0.00199	CcSEcCtD
Palonosetron—Asthenia—Thiotepa—sarcoma	0.000707	0.00198	CcSEcCtD
Palonosetron—Infection—Etoposide—sarcoma	0.000703	0.00197	CcSEcCtD
Palonosetron—Abdominal distension—Epirubicin—sarcoma	0.000703	0.00197	CcSEcCtD
Palonosetron—Asthenia—Dactinomycin—sarcoma	0.000702	0.00197	CcSEcCtD
Palonosetron—Pruritus—Thiotepa—sarcoma	0.000697	0.00196	CcSEcCtD
Palonosetron—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000696	0.00195	CcSEcCtD
Palonosetron—Tachycardia—Etoposide—sarcoma	0.000691	0.00194	CcSEcCtD
Palonosetron—Body temperature increased—Vincristine—sarcoma	0.000691	0.00194	CcSEcCtD
Palonosetron—Abdominal pain—Vincristine—sarcoma	0.000691	0.00194	CcSEcCtD
Palonosetron—Skin disorder—Etoposide—sarcoma	0.000688	0.00193	CcSEcCtD
Palonosetron—Abdominal pain upper—Doxorubicin—sarcoma	0.000682	0.00191	CcSEcCtD
Palonosetron—Hypokalaemia—Doxorubicin—sarcoma	0.00068	0.00191	CcSEcCtD
Palonosetron—Anorexia—Etoposide—sarcoma	0.000675	0.00189	CcSEcCtD
Palonosetron—Diarrhoea—Thiotepa—sarcoma	0.000674	0.00189	CcSEcCtD
Palonosetron—Body temperature increased—Mitoxantrone—sarcoma	0.000673	0.00189	CcSEcCtD
Palonosetron—Abdominal pain—Mitoxantrone—sarcoma	0.000673	0.00189	CcSEcCtD
Palonosetron—Aspartate aminotransferase increased—Doxorubicin—sarcoma	0.000673	0.00189	CcSEcCtD
Palonosetron—Diarrhoea—Dactinomycin—sarcoma	0.000669	0.00188	CcSEcCtD
Palonosetron—Hypotension—Etoposide—sarcoma	0.000662	0.00186	CcSEcCtD
Palonosetron—Gastritis—Doxorubicin—sarcoma	0.000661	0.00186	CcSEcCtD
Palonosetron—Dizziness—Thiotepa—sarcoma	0.000652	0.00183	CcSEcCtD
Palonosetron—Abdominal distension—Doxorubicin—sarcoma	0.00065	0.00182	CcSEcCtD
Palonosetron—Hypersensitivity—Vincristine—sarcoma	0.000644	0.00181	CcSEcCtD
Palonosetron—Paraesthesia—Etoposide—sarcoma	0.000636	0.00178	CcSEcCtD
Palonosetron—Dyspnoea—Etoposide—sarcoma	0.000631	0.00177	CcSEcCtD
Palonosetron—Hyperglycaemia—Epirubicin—sarcoma	0.00063	0.00177	CcSEcCtD
Palonosetron—Somnolence—Etoposide—sarcoma	0.00063	0.00177	CcSEcCtD
Palonosetron—Hypersensitivity—Mitoxantrone—sarcoma	0.000627	0.00176	CcSEcCtD
Palonosetron—Asthenia—Vincristine—sarcoma	0.000627	0.00176	CcSEcCtD
Palonosetron—Vomiting—Thiotepa—sarcoma	0.000627	0.00176	CcSEcCtD
Palonosetron—Vomiting—Dactinomycin—sarcoma	0.000622	0.00175	CcSEcCtD
Palonosetron—Rash—Thiotepa—sarcoma	0.000622	0.00174	CcSEcCtD
Palonosetron—Dermatitis—Thiotepa—sarcoma	0.000621	0.00174	CcSEcCtD
Palonosetron—Headache—Thiotepa—sarcoma	0.000618	0.00173	CcSEcCtD
Palonosetron—Rash—Dactinomycin—sarcoma	0.000617	0.00173	CcSEcCtD
Palonosetron—Decreased appetite—Etoposide—sarcoma	0.000616	0.00173	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Etoposide—sarcoma	0.000611	0.00172	CcSEcCtD
Palonosetron—Asthenia—Mitoxantrone—sarcoma	0.000611	0.00171	CcSEcCtD
Palonosetron—Fatigue—Etoposide—sarcoma	0.00061	0.00171	CcSEcCtD
Palonosetron—Pain—Etoposide—sarcoma	0.000606	0.0017	CcSEcCtD
Palonosetron—Constipation—Etoposide—sarcoma	0.000606	0.0017	CcSEcCtD
Palonosetron—Diarrhoea—Vincristine—sarcoma	0.000598	0.00168	CcSEcCtD
Palonosetron—Hepatobiliary disease—Epirubicin—sarcoma	0.000589	0.00165	CcSEcCtD
Palonosetron—Epistaxis—Epirubicin—sarcoma	0.000587	0.00165	CcSEcCtD
Palonosetron—Nausea—Thiotepa—sarcoma	0.000586	0.00164	CcSEcCtD
Palonosetron—Sinusitis—Epirubicin—sarcoma	0.000584	0.00164	CcSEcCtD
Palonosetron—Hyperglycaemia—Doxorubicin—sarcoma	0.000583	0.00163	CcSEcCtD
Palonosetron—Diarrhoea—Mitoxantrone—sarcoma	0.000582	0.00163	CcSEcCtD
Palonosetron—Nausea—Dactinomycin—sarcoma	0.000581	0.00163	CcSEcCtD
Palonosetron—Gastrointestinal pain—Etoposide—sarcoma	0.000579	0.00162	CcSEcCtD
Palonosetron—Dizziness—Vincristine—sarcoma	0.000578	0.00162	CcSEcCtD
Palonosetron—Bradycardia—Epirubicin—sarcoma	0.000569	0.0016	CcSEcCtD
Palonosetron—Abdominal pain—Etoposide—sarcoma	0.00056	0.00157	CcSEcCtD
Palonosetron—Body temperature increased—Etoposide—sarcoma	0.00056	0.00157	CcSEcCtD
Palonosetron—Vomiting—Vincristine—sarcoma	0.000556	0.00156	CcSEcCtD
Palonosetron—Urinary tract disorder—Epirubicin—sarcoma	0.000552	0.00155	CcSEcCtD
Palonosetron—Rash—Vincristine—sarcoma	0.000551	0.00155	CcSEcCtD
Palonosetron—Dermatitis—Vincristine—sarcoma	0.000551	0.00154	CcSEcCtD
Palonosetron—Connective tissue disorder—Epirubicin—sarcoma	0.000549	0.00154	CcSEcCtD
Palonosetron—Urethral disorder—Epirubicin—sarcoma	0.000548	0.00154	CcSEcCtD
Palonosetron—Headache—Vincristine—sarcoma	0.000548	0.00154	CcSEcCtD
Palonosetron—Hepatobiliary disease—Doxorubicin—sarcoma	0.000545	0.00153	CcSEcCtD
Palonosetron—Epistaxis—Doxorubicin—sarcoma	0.000543	0.00152	CcSEcCtD
Palonosetron—Vomiting—Mitoxantrone—sarcoma	0.000541	0.00152	CcSEcCtD
Palonosetron—Sinusitis—Doxorubicin—sarcoma	0.00054	0.00152	CcSEcCtD
Palonosetron—Rash—Mitoxantrone—sarcoma	0.000537	0.00151	CcSEcCtD
Palonosetron—Dermatitis—Mitoxantrone—sarcoma	0.000536	0.0015	CcSEcCtD
Palonosetron—Headache—Mitoxantrone—sarcoma	0.000533	0.0015	CcSEcCtD
Palonosetron—Bradycardia—Doxorubicin—sarcoma	0.000526	0.00148	CcSEcCtD
Palonosetron—Eye disorder—Epirubicin—sarcoma	0.000522	0.00146	CcSEcCtD
Palonosetron—Hypersensitivity—Etoposide—sarcoma	0.000522	0.00146	CcSEcCtD
Palonosetron—Tinnitus—Epirubicin—sarcoma	0.000521	0.00146	CcSEcCtD
Palonosetron—Nausea—Vincristine—sarcoma	0.000519	0.00146	CcSEcCtD
Palonosetron—Cardiac disorder—Epirubicin—sarcoma	0.000519	0.00145	CcSEcCtD
Palonosetron—Urinary tract disorder—Doxorubicin—sarcoma	0.000511	0.00143	CcSEcCtD
Palonosetron—Asthenia—Etoposide—sarcoma	0.000508	0.00143	CcSEcCtD
Palonosetron—Connective tissue disorder—Doxorubicin—sarcoma	0.000508	0.00143	CcSEcCtD
Palonosetron—Angiopathy—Epirubicin—sarcoma	0.000507	0.00142	CcSEcCtD
Palonosetron—Urethral disorder—Doxorubicin—sarcoma	0.000507	0.00142	CcSEcCtD
Palonosetron—Nausea—Mitoxantrone—sarcoma	0.000506	0.00142	CcSEcCtD
Palonosetron—Immune system disorder—Epirubicin—sarcoma	0.000505	0.00142	CcSEcCtD
Palonosetron—Mediastinal disorder—Epirubicin—sarcoma	0.000504	0.00141	CcSEcCtD
Palonosetron—Chills—Epirubicin—sarcoma	0.000501	0.00141	CcSEcCtD
Palonosetron—Pruritus—Etoposide—sarcoma	0.000501	0.00141	CcSEcCtD
Palonosetron—Arrhythmia—Epirubicin—sarcoma	0.000499	0.0014	CcSEcCtD
Palonosetron—Alopecia—Epirubicin—sarcoma	0.000494	0.00139	CcSEcCtD
Palonosetron—Mental disorder—Epirubicin—sarcoma	0.000489	0.00137	CcSEcCtD
Palonosetron—Erythema—Epirubicin—sarcoma	0.000486	0.00136	CcSEcCtD
Palonosetron—Malnutrition—Epirubicin—sarcoma	0.000486	0.00136	CcSEcCtD
Palonosetron—Diarrhoea—Etoposide—sarcoma	0.000484	0.00136	CcSEcCtD
Palonosetron—Eye disorder—Doxorubicin—sarcoma	0.000483	0.00136	CcSEcCtD
Palonosetron—Tinnitus—Doxorubicin—sarcoma	0.000482	0.00135	CcSEcCtD
Palonosetron—Cardiac disorder—Doxorubicin—sarcoma	0.00048	0.00135	CcSEcCtD
Palonosetron—Flatulence—Epirubicin—sarcoma	0.000479	0.00134	CcSEcCtD
Palonosetron—Dysgeusia—Epirubicin—sarcoma	0.000476	0.00134	CcSEcCtD
Palonosetron—Angiopathy—Doxorubicin—sarcoma	0.000469	0.00132	CcSEcCtD
Palonosetron—Dizziness—Etoposide—sarcoma	0.000468	0.00131	CcSEcCtD
Palonosetron—Immune system disorder—Doxorubicin—sarcoma	0.000467	0.00131	CcSEcCtD
Palonosetron—Mediastinal disorder—Doxorubicin—sarcoma	0.000466	0.00131	CcSEcCtD
Palonosetron—Chills—Doxorubicin—sarcoma	0.000464	0.0013	CcSEcCtD
Palonosetron—Arrhythmia—Doxorubicin—sarcoma	0.000462	0.0013	CcSEcCtD
Palonosetron—Alopecia—Doxorubicin—sarcoma	0.000457	0.00128	CcSEcCtD
Palonosetron—Mental disorder—Doxorubicin—sarcoma	0.000453	0.00127	CcSEcCtD
Palonosetron—Vomiting—Etoposide—sarcoma	0.00045	0.00126	CcSEcCtD
Palonosetron—Malnutrition—Doxorubicin—sarcoma	0.00045	0.00126	CcSEcCtD
Palonosetron—Erythema—Doxorubicin—sarcoma	0.00045	0.00126	CcSEcCtD
Palonosetron—Anaemia—Epirubicin—sarcoma	0.00045	0.00126	CcSEcCtD
Palonosetron—Rash—Etoposide—sarcoma	0.000446	0.00125	CcSEcCtD
Palonosetron—Dermatitis—Etoposide—sarcoma	0.000446	0.00125	CcSEcCtD
Palonosetron—Headache—Etoposide—sarcoma	0.000444	0.00124	CcSEcCtD
Palonosetron—Flatulence—Doxorubicin—sarcoma	0.000443	0.00124	CcSEcCtD
Palonosetron—Dysgeusia—Doxorubicin—sarcoma	0.000441	0.00124	CcSEcCtD
Palonosetron—Convulsion—Epirubicin—sarcoma	0.000421	0.00118	CcSEcCtD
Palonosetron—Nausea—Etoposide—sarcoma	0.000421	0.00118	CcSEcCtD
Palonosetron—Hypertension—Epirubicin—sarcoma	0.00042	0.00118	CcSEcCtD
Palonosetron—Anaemia—Doxorubicin—sarcoma	0.000416	0.00117	CcSEcCtD
Palonosetron—Myalgia—Epirubicin—sarcoma	0.000414	0.00116	CcSEcCtD
Palonosetron—Arthralgia—Epirubicin—sarcoma	0.000414	0.00116	CcSEcCtD
Palonosetron—Anxiety—Epirubicin—sarcoma	0.000413	0.00116	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000411	0.00115	CcSEcCtD
Palonosetron—Discomfort—Epirubicin—sarcoma	0.000409	0.00115	CcSEcCtD
Palonosetron—Dry mouth—Epirubicin—sarcoma	0.000405	0.00114	CcSEcCtD
Palonosetron—Anaphylactic shock—Epirubicin—sarcoma	0.000397	0.00111	CcSEcCtD
Palonosetron—Infection—Epirubicin—sarcoma	0.000394	0.00111	CcSEcCtD
Palonosetron—Shock—Epirubicin—sarcoma	0.000391	0.0011	CcSEcCtD
Palonosetron—Convulsion—Doxorubicin—sarcoma	0.00039	0.00109	CcSEcCtD
Palonosetron—Nervous system disorder—Epirubicin—sarcoma	0.000389	0.00109	CcSEcCtD
Palonosetron—Hypertension—Doxorubicin—sarcoma	0.000389	0.00109	CcSEcCtD
Palonosetron—Tachycardia—Epirubicin—sarcoma	0.000387	0.00109	CcSEcCtD
Palonosetron—Skin disorder—Epirubicin—sarcoma	0.000386	0.00108	CcSEcCtD
Palonosetron—Arthralgia—Doxorubicin—sarcoma	0.000383	0.00107	CcSEcCtD
Palonosetron—Myalgia—Doxorubicin—sarcoma	0.000383	0.00107	CcSEcCtD
Palonosetron—Anxiety—Doxorubicin—sarcoma	0.000382	0.00107	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.00038	0.00107	CcSEcCtD
Palonosetron—Discomfort—Doxorubicin—sarcoma	0.000379	0.00106	CcSEcCtD
Palonosetron—Anorexia—Epirubicin—sarcoma	0.000378	0.00106	CcSEcCtD
Palonosetron—Dry mouth—Doxorubicin—sarcoma	0.000375	0.00105	CcSEcCtD
Palonosetron—Hypotension—Epirubicin—sarcoma	0.000371	0.00104	CcSEcCtD
Palonosetron—Anaphylactic shock—Doxorubicin—sarcoma	0.000367	0.00103	CcSEcCtD
Palonosetron—Infection—Doxorubicin—sarcoma	0.000365	0.00102	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000362	0.00101	CcSEcCtD
Palonosetron—Shock—Doxorubicin—sarcoma	0.000361	0.00101	CcSEcCtD
Palonosetron—Nervous system disorder—Doxorubicin—sarcoma	0.00036	0.00101	CcSEcCtD
Palonosetron—Insomnia—Epirubicin—sarcoma	0.000359	0.00101	CcSEcCtD
Palonosetron—Tachycardia—Doxorubicin—sarcoma	0.000358	0.00101	CcSEcCtD
Palonosetron—Skin disorder—Doxorubicin—sarcoma	0.000357	0.001	CcSEcCtD
Palonosetron—Paraesthesia—Epirubicin—sarcoma	0.000356	0.001	CcSEcCtD
Palonosetron—Dyspnoea—Epirubicin—sarcoma	0.000354	0.000993	CcSEcCtD
Palonosetron—Somnolence—Epirubicin—sarcoma	0.000353	0.00099	CcSEcCtD
Palonosetron—Anorexia—Doxorubicin—sarcoma	0.00035	0.000982	CcSEcCtD
Palonosetron—Dyspepsia—Epirubicin—sarcoma	0.000349	0.00098	CcSEcCtD
Palonosetron—Decreased appetite—Epirubicin—sarcoma	0.000345	0.000968	CcSEcCtD
Palonosetron—Hypotension—Doxorubicin—sarcoma	0.000343	0.000963	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Epirubicin—sarcoma	0.000343	0.000961	CcSEcCtD
Palonosetron—Fatigue—Epirubicin—sarcoma	0.000342	0.00096	CcSEcCtD
Palonosetron—Pain—Epirubicin—sarcoma	0.000339	0.000952	CcSEcCtD
Palonosetron—Constipation—Epirubicin—sarcoma	0.000339	0.000952	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000335	0.000939	CcSEcCtD
Palonosetron—Insomnia—Doxorubicin—sarcoma	0.000332	0.000932	CcSEcCtD
Palonosetron—Paraesthesia—Doxorubicin—sarcoma	0.00033	0.000925	CcSEcCtD
Palonosetron—Dyspnoea—Doxorubicin—sarcoma	0.000327	0.000919	CcSEcCtD
Palonosetron—Somnolence—Doxorubicin—sarcoma	0.000327	0.000916	CcSEcCtD
Palonosetron—Gastrointestinal pain—Epirubicin—sarcoma	0.000325	0.000911	CcSEcCtD
Palonosetron—Dyspepsia—Doxorubicin—sarcoma	0.000323	0.000907	CcSEcCtD
Palonosetron—Decreased appetite—Doxorubicin—sarcoma	0.000319	0.000896	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000317	0.00089	CcSEcCtD
Palonosetron—Fatigue—Doxorubicin—sarcoma	0.000317	0.000888	CcSEcCtD
Palonosetron—Constipation—Doxorubicin—sarcoma	0.000314	0.000881	CcSEcCtD
Palonosetron—Pain—Doxorubicin—sarcoma	0.000314	0.000881	CcSEcCtD
Palonosetron—Abdominal pain—Epirubicin—sarcoma	0.000314	0.00088	CcSEcCtD
Palonosetron—Body temperature increased—Epirubicin—sarcoma	0.000314	0.00088	CcSEcCtD
Palonosetron—Gastrointestinal pain—Doxorubicin—sarcoma	0.0003	0.000843	CcSEcCtD
Palonosetron—Hypersensitivity—Epirubicin—sarcoma	0.000292	0.00082	CcSEcCtD
Palonosetron—Body temperature increased—Doxorubicin—sarcoma	0.00029	0.000814	CcSEcCtD
Palonosetron—Abdominal pain—Doxorubicin—sarcoma	0.00029	0.000814	CcSEcCtD
Palonosetron—Asthenia—Epirubicin—sarcoma	0.000285	0.000799	CcSEcCtD
Palonosetron—Pruritus—Epirubicin—sarcoma	0.000281	0.000788	CcSEcCtD
Palonosetron—Diarrhoea—Epirubicin—sarcoma	0.000272	0.000762	CcSEcCtD
Palonosetron—Hypersensitivity—Doxorubicin—sarcoma	0.000271	0.000759	CcSEcCtD
Palonosetron—Asthenia—Doxorubicin—sarcoma	0.000264	0.000739	CcSEcCtD
Palonosetron—Dizziness—Epirubicin—sarcoma	0.000262	0.000736	CcSEcCtD
Palonosetron—Pruritus—Doxorubicin—sarcoma	0.00026	0.000729	CcSEcCtD
Palonosetron—Vomiting—Epirubicin—sarcoma	0.000252	0.000708	CcSEcCtD
Palonosetron—Diarrhoea—Doxorubicin—sarcoma	0.000251	0.000705	CcSEcCtD
Palonosetron—Rash—Epirubicin—sarcoma	0.00025	0.000702	CcSEcCtD
Palonosetron—Dermatitis—Epirubicin—sarcoma	0.00025	0.000701	CcSEcCtD
Palonosetron—Headache—Epirubicin—sarcoma	0.000249	0.000698	CcSEcCtD
Palonosetron—Dizziness—Doxorubicin—sarcoma	0.000243	0.000681	CcSEcCtD
Palonosetron—Nausea—Epirubicin—sarcoma	0.000236	0.000661	CcSEcCtD
Palonosetron—Vomiting—Doxorubicin—sarcoma	0.000234	0.000655	CcSEcCtD
Palonosetron—Rash—Doxorubicin—sarcoma	0.000232	0.00065	CcSEcCtD
Palonosetron—Dermatitis—Doxorubicin—sarcoma	0.000231	0.000649	CcSEcCtD
Palonosetron—Headache—Doxorubicin—sarcoma	0.00023	0.000645	CcSEcCtD
Palonosetron—Nausea—Doxorubicin—sarcoma	0.000218	0.000612	CcSEcCtD
